A VACCINIA VIRUS HERPES-SIMPLEX VIRUS (HSV) GLYCOPROTEIN B1 RECOMBINANT OR AN HSV VACCINE OVERCOME THE HSV TYPE-2 INDUCED HUMORAL IMMUNOSUPPRESSION AND PROTECT AGAINST VAGINAL CHALLENGE IN BALB/C MICE

被引:6
作者
FLECK, M [1 ]
PODLECH, J [1 ]
WEISE, K [1 ]
FALKE, D [1 ]
机构
[1] INST MED MICROBIOL,DIV EXPTL VIROL,D-55101 MAINZ,GERMANY
关键词
D O I
10.1007/BF00277159
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary infections with herpes simplex virus type 2 (HSV-2) suppress the antibody response to secondary HSV-1 and -2 infections in the BALB/c mouse. In contrast, a challenge by the i.p. route using a vaccinia virus-HSV-1 glycoprotein B (VV gB 1) recombinant induces a significant enhancement of the antibody response. This booster reaction is also observed if a challenge with a formalin-inactivated HSV-1 vaccine is performed. Although no or low humoral and vaginal antibodies are detectable after a single i.p. infection with the VV gB1 recombinant or the HSV-1 vaccine, protection against vaginal challenge with HSV-2 is induced. This points to the important role of cellular immunity for vaginal infections.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 50 条
  • [41] EFFECTOR MECHANISMS IN THE INDUCED RESISTANCE AGAINST LETHAL HERPES-SIMPLEX TYPE-2 (HSV2) INFECTIONS IN MICE
    ARMERDING, D
    ROSSITER, H
    MEYER, P
    [J]. ZEITSCHRIFT FUR IMMUNITATSFORSCHUNG-IMMUNOBIOLOGY, 1979, 156 (03): : 201 - 201
  • [42] PREVALENCE OF GENITAL HERPES AND OR HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2) ANTIBODIES IN 2 OBSTETRIC POPULATIONS
    KEYSERLING, H
    THOMPSON, S
    ROBINOWITZ, M
    LEE, F
    PEREIRA, L
    COLEMAN, RM
    BAIN, R
    NAHMIAS, A
    [J]. PEDIATRIC RESEARCH, 1985, 19 (04) : A297 - A297
  • [43] A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2
    Burn, Clare
    Ramsey, Natalie
    Garforth, Scott J.
    Almo, Steven
    Jacobs, William R., Jr.
    Herold, Betsy C.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (05) : 754 - 758
  • [44] Evaluation of a dominant-negative recombinant herpes simplex virus (HSV) type 1 as a vaccine against genital herpes in mice und guinea pigs
    Brans, R.
    [J]. HAUTARZT, 2010, 61 (12): : 1073 - 1077
  • [45] INVOLVEMENT OF GLYCOPROTEIN-C (GC) IN ADSORPTION OF HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) TO THE CELL
    SVENNERHOLM, B
    JEANSSON, S
    VAHLNE, A
    LYCKE, E
    [J]. ARCHIVES OF VIROLOGY, 1991, 120 (3-4) : 273 - 279
  • [46] EXPRESSION OF HERPES-SIMPLEX VIRUS-1 GLYCOPROTEIN-B BY A RECOMBINANT VACCINIA VIRUS AND PROTECTION OF MICE AGAINST LETHAL HERPES-SIMPLEX VIRUS-1 INFECTION
    CANTIN, EM
    EBERLE, R
    BALDICK, JL
    MOSS, B
    WILLEY, DE
    NOTKINS, AL
    OPENSHAW, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) : 5908 - 5912
  • [47] CLINICAL AND SEROLOGICAL OUTCOME OF GENITAL HERPES-SIMPLEX VIRUS (HSV) TYPE-2 INOCULATION FOLLOWING ORAL HSV TYPE-1 INFECTION IN GUINEA-PIGS
    BERNSTEIN, DI
    LEE, FK
    ECHLER, G
    NAHMIAS, AJ
    [J]. JOURNAL OF GENERAL VIROLOGY, 1989, 70 : 2365 - 2372
  • [48] VIRUS TRANSCRIPTS IN LETHAL AND NON-LETHAL CENTRAL NERVOUS INFECTION WITH HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2) IN MICE
    SUZUKI, S
    MARTIN, JR
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1988, 47 (03) : 306 - 306
  • [49] BACULOVIRUS-EXPRESSED GLYCOPROTEIN-H OF HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) INDUCES NEUTRALIZING ANTIBODY AND DELAYED-TYPE HYPERSENSITIVITY RESPONSES, BUT DOES NOT PROTECT IMMUNIZED MICE AGAINST LETHAL HSV-1 CHALLENGE
    GHIASI, H
    KAIWAR, R
    NESBURN, AB
    WECHSLER, SL
    [J]. JOURNAL OF GENERAL VIROLOGY, 1992, 73 : 719 - 722
  • [50] EFFECTS OF INVIVO DEPLETION OF IMMUNOCYTE POPULATIONS ON HERPES-SIMPLEX VIRUS GLYCOPROTEIN-D VACCINE-INDUCED RESISTANCE TO HSV2 CHALLENGE
    MISHKIN, EM
    BLASIAK, M
    GIORGIO, D
    ISHIZAKA, ST
    [J]. VIRAL IMMUNOLOGY, 1992, 5 (02) : 151 - 161